Knife-Edge Rebound: TNYA Setting Up for a 0.70→0.75 Pivot-to-R1 Bounce

Step-by-step multi-timeframe read of TNYA (Tenaya Therapeutics) with 24h trading plan

Context and structure

• Asset profile: Small-cap biotech now trading as a sub-$1 penny stock post event-driven gap-down (12/12). Expect very high volatility, headline risk, and outsized intraday ranges. Liquidity is adequate but uneven; slippage risk is material.
• Objective: Predict next 24h price path and define an actionable, risk-aware trade with optimal open and close levels.

Price action recap (daily)

• Pre-crash uptrend into early Oct peaked near ~2.35, rolled into a downtrend through Nov–early Dec (1.40–1.20 area), then a capitulation gap-down on 12/12 to 0.85 close (range 1.05/0.785/0.85) on 66.6M shares.
• Post-gap behavior: Series of lower closes into 12/17–12/18 double-touch lows ~0.667, then a 3-session relief bounce to 0.757 on 12/22.
• 12/23 session: Wide range 0.7456 high to 0.655 low, close 0.7032 on elevated volume (~8.48M). Intraday path showed strong low rejection and end-of-day stabilization around 0.70–0.71.

Intraday structure (today’s 30–60 min bars)

• Early sell program took price to 0.6549 (sweep of 12/17–18 lows), then series of higher lows: ~0.6813 → 0.6862 → 0.6906, with repeated caps near 0.709–0.71. That’s a developing ascending triangle under a horizontal lid at ~0.71.
• Late-session reclaim above ~0.70 and brief prints to ~0.7082 indicate buyers defended the 0.70 handle and accepted price above intraday VWAP into the close.

Key levels (confluence)

• Support: 0.655–0.66 (multi-touch structural floor: 12/17–18 and intraday 12/23 LOD), 0.68–0.69 (intraday higher-low cluster), 0.700–0.702 (classic pivot region).
• Resistance: 0.709–0.712 (intraday lid), 0.733 (premarket 12/23 and 12/09–12/11 congestion echo), 0.745–0.75 (round-number and supply shelf), 0.757–0.767 (12/22 close/high), 0.79 (upper bounce objective). Large overhang above 0.80–0.85 from bagholders and the 12/12 gap body.

Pivot math (classic, based on 12/23 H/L/C)

• P = (H + L + C) / 3 = (0.7456 + 0.6550 + 0.7032) / 3 ≈ 0.7013
• R1 = 2P – L ≈ 0.7475
• S1 = 2P – H ≈ 0.6569
• R2 = P + (H – L) ≈ 0.7919
• S2 = P – (H – L) ≈ 0.6107 Interpretation: Price closed near P and above the 0.70 pivot area, with a textbook R1 magnet at ~0.748 that aligns with overhead supply at 0.745–0.75.

Trend and moving averages

• Short-term: 5-day SMA ≈ 0.699 (price ~0.703) – micro reclaim; 10-day SMA ≈ 0.867 – far overhead. All mid/long MAs (20/50/100) remain well above price; secular trend still down.
• EMA ribbon (qualitative): 5/9 EMA beginning to flatten post-capitulation; 21/50 EMA still declining. Short-term basing attempts inside a dominant downtrend.

Volatility and range statistics

• ATR(5) rough ≈ 0.08–0.09 (recent daily ranges 0.069–0.091). That implies typical 24h swing potential of ±$0.07–0.09 around the open.
• Bollinger Bands(20): Midline (approx 20SMA) still elevated (~0.85+) with expansive lower band; price trades in the lower quartile of the band structure but above the extreme tail seen mid-last week. Expect mean reversion rallies to stall under 0.80 until event risk resolves.
• Keltner Channels(20, ATR): Price near/below lower KC; short-term bounces are common when KC and BB both show lower-tail clustering.

Momentum/oscillators

• RSI(14) daily: Deeply oversold (qualitatively sub-30; likely teens/20s due to 12/12 shock). RSI rebounded with the 12/22 bounce; 12/23 close near 0.703 keeps RSI low but improving. This favors a tactical bounce over the next session(s).
• Stochastic RSI: Rising from oversold on intraday frames; supports a push toward the 0.71–0.75 lid if early buyers show.
• MACD (daily): Strongly negative but histogram contraction post 12/17–18 suggests bearish momentum is decelerating; potential for a daily bull cross later only if price can sustain above ~0.73–0.75 in coming days. Intraday MACD already flipped positive late day.
• Intraday bullish divergence: Price made a marginal lower low (~0.655) vs 12/17–18 (~0.667), but momentum (RSI/MACD) made higher lows on 30–60m – constructive for a bounce attempt.

Volume, money flow, and participation

• Capitulation signature 12/12 (66.6M) followed by lower but persistent volumes. 12/22–23 volume uptick into the bounce/base indicates two-way trade and early accumulation at sub-0.70s.
• OBV/Accum-Distribution (qualitative): Massive down impulse on 12/12, flattening since 12/18; 12/23’s close above day’s mid confirms some absorption of supply at the lows.
• VWAP dynamics: Intraday reclaim of VWAP into the close; an open near/above VWAP historically favors squeezes toward R1 in such post-capitulation setups.

Market structure and pattern analysis

• Pattern: Ascending triangle on intraday under 0.71 cap. Measured move of triangle break (height ~0.709–0.655 ≈ 0.054) projects to ~0.763 on a clean break/hold over 0.71–0.72, aligning with 12/22 high zone (0.757–0.767).
• Fibonacci micro swing (12/17 low 0.667 to 12/22 high 0.767): 61.8% retrace ≈ 0.706; price closed around 0.703–0.706 – classic golden-ratio retest area. Holding this zone favors a bounce toward 0.74–0.76.
• Donchian channel (20d): New lower boundary printed ~0.655; sweeping and reclaiming above it intraday is a tactical buy signal for mean reversion.

Ichimoku (daily, qualitative)

• Price well below cloud; Tenkan/Kijun far overhead. No trend reversal signal yet. However, the gap between price and baseline suggests short-term snapbacks can be sharp when buyers step in.

Event/gap framework

• 12/12 gap-down remains largely unfilled; immediate full gap-fill is improbable without a new positive catalyst. Near-term upside likely capped under 0.80–0.85 where heavy supply lives.

Relative/flow context

• Beta to XBI/IBB: High beta typical; if biotech ETFs are firm next session, that tailwind could help the 0.71 breakout attempt. Conversely, any sector weakness could push a retest of 0.68/0.66.

Risk mapping and scenario analysis (next 24h)

• Bull case (45%): Early hold above pivot (≈0.701) → quick test/break of 0.709–0.712 → momentum push to R1 0.747–0.75; extension risk to 0.757–0.763 if volume expands through lid.
• Base/chop (35%): Range 0.68–0.71 persists; multiple tests of pivot with fades under 0.71; closes near 0.70–0.72.
• Bear case (20%): Early failure of 0.70 pivot → flush to 0.68 and sweep of 0.655 S1 region; deeper extension risk to S2 ≈ 0.611 only on heavy sell flows or new negative headlines.

Confluences supporting a tactical long

• Multiple-support confluence: Prior swing lows (0.667), today’s S1 (0.657), and 61.8% retrace (0.706) cluster around the current price.
• Pivot/R1 map: Closing near P with a well-defined R1 target (0.7475) that aligns with structural supply (0.745–0.75) – a natural magnet for day-two continuation bounces.
• Intraday structure: Higher lows into close with VWAP reclaim and ascending triangle under 0.71.
• Momentum regime: Deeply oversold daily RSI with intraday momentum turning up – typical of dead-cat bounce continuations.

Risk management and execution

• Entry logic: Buy near the daily pivot (≈0.701) on a small pullback or first consolidation above 0.70; alternatively, buy a breakout retest of 0.712 with tighter stop.
• Stop (not asked but essential): Below 0.682 (beneath intraday base and pre-break structure) or more conservative below 0.655 (S1/LOD sweep) depending on risk tolerance.
• Targeting: First TP at R1 ≈ 0.748; stretch TP 0.757–0.763 if 0.75 clears on volume.
• R:R: From ~0.701 entry to 0.748 target ≈ +0.047 vs stop 0.682 (−0.019) yields ~2.5:1. Using 0.675 stop (beneath deeper support) still ~1.3–1.5:1 to first target, better to second target.

Final 24h view

• Bias: Moderately bullish for a continuation bounce toward 0.745–0.75, contingent on holding the 0.70 pivot early. Breakdown risk rises materially below 0.69; invalidate on decisive loss of 0.655.
• Trade: Tactical long into R1 with partials near 0.745–0.75; reassess extension to 0.757–0.763 only if volume and tape confirm.